ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Lancet: 10-20-30 targets to address AMR by 2030
Developing systemic & inhaled antibiotics for lung infections
Lessons in Discovery from Lynn Silver + Pro-con on alternatives to antibiotics
Push! Pull! Push! Pull! / Highlights from Davos 2018
What does an antibiotic cost to develop? What is it worth? How to afford it?
Draft FDA guidance on anti-infectives for children: It’s (mostly) all about PK and safety
Plazomicin (Achaogen) financial post-mortem: #PassPASTEUR
New pipeline analysis: Cancer projects were funded 17x more than antibacterials during 2011-2020
COVID-19 and the Long-Term Trajectory of AMR Efforts: Wellcome Trust Deep Dive
FDA analysis of 40-years of antibacterial development: Dheman et al.
Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?
FDA and EMA regulatory updates / Fireside chat during the 4th AMR Conference
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet